Aalto Pharma AG is a Swiss pharmaceutical company focused on supramolecular API delivery for treating topical infections in humans and animals. The company develops and manufactures supramolecular molecules and a patented delivery platform, which the website describes as non-toxic, non-comedogenic and non-cauterising, and reports bactericidal activity against antibiotic-resistant bacteria such as E. coli, A. baumannii and P. aeruginosa.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Dermatological conditions, fungal nail infections, viral skin and mucous membrane infections, burn wounds and wound care, dental caries and gingivitis.
Supramolecular Drug Delivery Technology
Supramolecular API delivery with an intelligent polymeric carrier for the treatment of topical infections; development and manufacture of solutions for human and veterinary medicine.
Partnering and In-Licensing
Partnering, in-licensing and product co-development for international markets focusing on silver ion based products and multiple therapeutic indications.
Knowledge
No knowledge articles yet
Once Aalto Pharma AG has claimed this profile, we'll publish editorial articles and case studies here together.